These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 16734547)
1. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Paty BW; Senior PA; Lakey JR; Shapiro AM; Ryan EA Diabetes Technol Ther; 2006 Apr; 8(2):165-73. PubMed ID: 16734547 [TBL] [Abstract][Full Text] [Related]
3. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Zisser HC; Bevier WC; Jovanovic L Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605 [TBL] [Abstract][Full Text] [Related]
4. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Kessler L; Passemard R; Oberholzer J; Benhamou PY; Bucher P; Toso C; Meyer P; Penfornis A; Badet L; Wolf P; Colin C; Morel P; Pinget M; Diabetes Care; 2002 Dec; 25(12):2256-62. PubMed ID: 12453970 [TBL] [Abstract][Full Text] [Related]
5. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Tanenberg R; Bode B; Lane W; Levetan C; Mestman J; Harmel AP; Tobian J; Gross T; Mastrototaro J Mayo Clin Proc; 2004 Dec; 79(12):1521-6. PubMed ID: 15595336 [TBL] [Abstract][Full Text] [Related]
6. Association between the secretory unit of islet transplant objects index and satisfaction with insulin therapy among insulin-dependent islet recipients. Takita M; Matsumoto S; Shimoda M; Chujo D; Itoh T; Iwahashi S; SoRelle JA; Onaca N; Naziruddin B; Levy MF Transplant Proc; 2011 Nov; 43(9):3250-5. PubMed ID: 22099769 [TBL] [Abstract][Full Text] [Related]
7. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. McCall AL; Cox DJ; Crean J; Gloster M; Kovatchev BP Diabetes Technol Ther; 2006 Dec; 8(6):644-53. PubMed ID: 17109596 [TBL] [Abstract][Full Text] [Related]
8. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Ryan EA; Shandro T; Green K; Paty BW; Senior PA; Bigam D; Shapiro AM; Vantyghem MC Diabetes; 2004 Apr; 53(4):955-62. PubMed ID: 15047610 [TBL] [Abstract][Full Text] [Related]
10. [Accuracy, effect on insulin therapy and glycemic control and complications of the continuous glucose monitoring system in type 1 diabetic patients]. Maia FF; Araújo LR Arq Bras Endocrinol Metabol; 2005 Aug; 49(4):563-8. PubMed ID: 16358086 [TBL] [Abstract][Full Text] [Related]
11. A patient with severe, recurrent hypoglycemia and glycemic lability who underwent islet transplantation. Ryan EA; Shapiro AJ Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):349-53; quiz 354. PubMed ID: 16932312 [TBL] [Abstract][Full Text] [Related]
12. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1]. Głowińska-Olszewska B; Urban M; Peczyńska J; Florys B; Kowalewski M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):237-43. PubMed ID: 16232362 [TBL] [Abstract][Full Text] [Related]
13. Insulin independence of unstable diabetic patient after single living donor islet transplantation. Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive health assessment and five-yr follow-up of allogeneic islet transplant recipients. Radosevich DM; Jevne R; Bellin M; Kandaswamy R; Sutherland DE; Hering BJ Clin Transplant; 2013; 27(6):E715-24. PubMed ID: 24304379 [TBL] [Abstract][Full Text] [Related]
15. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Ghofaili KA; Fung M; Ao Z; Meloche M; Shapiro RJ; Warnock GL; Elahi D; Meneilly GS; Thompson DM Transplantation; 2007 Jan; 83(1):24-8. PubMed ID: 17220786 [TBL] [Abstract][Full Text] [Related]
16. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Paty BW; Ryan EA; Shapiro AM; Lakey JR; Robertson RP Diabetes; 2002 Dec; 51(12):3428-34. PubMed ID: 12453896 [TBL] [Abstract][Full Text] [Related]
17. Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Kovatchev BP; Clarke WL; Breton M; Brayman K; McCall A Diabetes Technol Ther; 2005 Dec; 7(6):849-62. PubMed ID: 16386091 [TBL] [Abstract][Full Text] [Related]